sequencing of therapies in egfr-mutant nsclc
Published 8 years ago • 366 plays • Length 3:24Download video MP4
Download video MP3
Similar videos
-
5:10
sequencing egfr-targeted therapies in nsclc
-
2:50
sequencing with osimertinib in egfr-mutated nsclc
-
1:58
dr. bazhenova on sequencing beyond progression in egfr-mutant nsclc
-
28:28
patient selection, therapeutic sequencing, & treatment selection in egfr mutation-positive nsclc
-
3:57
sequencing with osimertinib in egfr-positive nsclc
-
8:31
resistance mechanisms and sequencing for egfr nsclc
-
1:57
dr. piotrowska on treatment for egfr-mutant nsclc
-
5:45
egfr tki sequencing
-
1:34
dr. konduri on sequencing therapy in egfr nsclc
-
1:08:18
next generation sequencing for egfr mutant lung cancer: how it guides treatment today & tomorrow
-
3:17
egfr resistance mechanisms and sequencing strategies
-
1:01
dr. shum on emerging targeted therapies in egfr-mutant nsclc
-
2:00
dr. goldberg on sequencing following treatment with osimertinib in nsclc
-
2:02
evolutions in the treatment of egfr-mutated nsclc
-
1:06
dr. goldman on targeted therapy options for egfr-, alk-, and ros1-mutated nsclc
-
3:47
afatinib therapy for uncommon egfr alterations in nsclc
-
5:00
options for up-front therapy in egfr-mutant nsclc
-
3:54
sequencing therapies in alk nsclc
-
4:07
chemotherapy with i-o therapy in egfr- or alk-mutated nsclc